Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease

Background: Oral anticoagulants (OAC) plus antiplatelets is recommended for patients with atrial fibrillation (AF) and coronary artery disease (CAD) to reduce thromboembolism. However, there is limited evidence regarding antithrombotic therapy for patients with concomitant chronic kidney disease (CK...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kuo-Hua, Ou, Shuo-Ming, Chu, Yuan-Chia, Lin, Yao-Ping, Tsai, Ming-Tsun, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531471/
https://www.ncbi.nlm.nih.gov/pubmed/34692798
http://dx.doi.org/10.3389/fcvm.2021.751359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531471/
https://www.ncbi.nlm.nih.gov/pubmed/34692798
http://dx.doi.org/10.3389/fcvm.2021.751359

Ejemplares similares